Egetis Therapeutics AB (publ) (STO:EGTX)

Egetis Therapeutics AB Statistics

Total Valuation

STO:EGTX has a market cap or net worth of SEK 2.61 billion. The enterprise value is 2.50 billion.

Market Cap	2.61B
Enterprise Value	2.50B

Important Dates

The next estimated earnings date is Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:EGTX has 395.16 million shares outstanding. The number of shares has increased by 21.06% in one year.

Current Share Class	395.16M
Shares Outstanding	395.16M
Shares Change (YoY)	+21.06%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	10.25%
Owned by Institutions (%)	18.63%
Float	231.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	55.14
PB Ratio	7.34
P/TBV Ratio	7.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.42
EV / Sales	52.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.31

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.27.

Current Ratio	1.09
Quick Ratio	1.06
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-0.40
Interest Coverage	-14.80

Financial Efficiency

Return on equity (ROE) is -89.14% and return on invested capital (ROIC) is -41.64%.

Return on Equity (ROE)	-89.14%
Return on Assets (ROA)	-30.85%
Return on Invested Capital (ROIC)	-41.64%
Return on Capital Employed (ROCE)	-75.08%
Revenue Per Employee	1.18M
Profits Per Employee	-8.43M
Employee Count	40
Asset Turnover	0.07
Inventory Turnover	23.67

Taxes

In the past 12 months, STO:EGTX has paid 300,000 in taxes.

Income Tax	300,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.34% in the last 52 weeks. The beta is 1.26, so STO:EGTX's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	+50.34%
50-Day Moving Average	5.46
200-Day Moving Average	4.84
Relative Strength Index (RSI)	69.67
Average Volume (20 Days)	1,105,957

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:EGTX had revenue of SEK 47.30 million and -337.20 million in losses. Loss per share was -1.00.

Revenue	47.30M
Gross Profit	18.90M
Operating Income	-321.10M
Pretax Income	-336.90M
Net Income	-337.20M
EBITDA	-317.60M
EBIT	-321.10M
Loss Per Share	-1.00

Balance Sheet

The company has 202.60 million in cash and 96.80 million in debt, giving a net cash position of 105.80 million or 0.27 per share.

Cash & Cash Equivalents	202.60M
Total Debt	96.80M
Net Cash	105.80M
Net Cash Per Share	0.27
Equity (Book Value)	355.10M
Book Value Per Share	0.99
Working Capital	19.70M

Cash Flow

In the last 12 months, operating cash flow was -241.20 million and capital expenditures -1.50 million, giving a free cash flow of -242.70 million.

Operating Cash Flow	-241.20M
Capital Expenditures	-1.50M
Free Cash Flow	-242.70M
FCF Per Share	-0.61

Margins

Gross Margin	39.96%
Operating Margin	-678.86%
Pretax Margin	-712.26%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:EGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.06%
Shareholder Yield	-21.06%
Earnings Yield	-12.93%
FCF Yield	-9.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:EGTX has an Altman Z-Score of -1.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.9
Piotroski F-Score	2